Hamilton Lane's tokenized HLSCOPE fund launches on Tron, marking first Securitize product issued on the once-maligned blockchain
Hamilton Lane is launching its tokenized Senior Credit Opportunities Fund (HLSCOPE) on TRON, marking the first Securitize-issued asset to launch on the once-maligned blockchain.
Launched in 2023, HLSCOPE is a tokenized feeder fund that provides onchain exposure to Hamilton Lane’s Senior Credit Opportunities Fund (SCOPE), an evergreen private credit strategy that invests primarily in senior secured loans to top-tier borrowers in North America and Europe.
HLSCOPE currently lives on the Ethereum mainnet, and Polygon, Plume, and Optimism networks, with some cross-chain maneuverability via Wormhole, according to Securitize’s website. The onchain fund has about $4.28 million in assets under management, and is advertising a 5.87% annual return.
The move is part of a trend of crypto firms embracing Tron in the wake of the Securities and Exchange Commission dropping its case against the blockchain and its founder, Justin Sun. U.S. firms like Anchorage and Securitize have since announced a willingness to launch products on Tron, which previously carried a heightened regulatory risk.
"Tokenization reaches its full potential when institutional-grade assets can operate on blockchain networks built for global scale," Securitize CEO Carlos Domingo said. "Bringing HLSCOPE to TRON marks an important milestone not only because it is the first Securitize asset launching on the network, but because it expands access to private markets through infrastructure designed for continuous, global financial activity. This is another step toward a more connected and interoperable onchain financial system."
TRON is one of the most active blockchains by volume, driven primarily by its significant stablecoin activity. Tuesday’s announcement notes that the HLSCOPE launch on TRON will bring the fund in front of 383 million accounts.
Notably, the SEC dropped its case against Sun and the Tron Foundation Limited and BitTorrent Foundation with prejudice, meaning it cannot be refiled. Rainberry Inc., the corporate parent for the BitTorrent network, which Sun acquired, agreed to pay a $10 million civil penalty for wash trading violations.
The SEC had sued Sun and those three firms in March 2023, alleging they had perpetrated unregistered securities offerings and sales of TRX and BTT, and accused them of market manipulation and paying celebrities to promote the tokens without proper disclosure.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion
The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.
Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market
Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.
Crypto prices
More
